Intercept Pharmaceuticals(ICPT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ICPT Intercept Pharmaceuticals

Halted 11-07 16:00:00 EST

19.00

+0.00

0.00%

High19.00	Low19.00	Vol0.00
Open19.00	D1 Closing19.00	Amplitude0.00%
Mkt Cap794.69M	Tradable Cap697.21M	Total Shares41.83M
T/O75.31M	T/O Rate0.00%	Tradable Shares36.70M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ICPT","market":"US","secType":"STK","nameCN":"Intercept Pharmaceuticals","latestPrice":19,"timestamp":1699390800000,"preClose":19,"halted":3,"volume":0,"delay":0,"floatShares":36695078,"shares":41825966,"eps":-1.479806,"marketStatus":"Halted","change":0,"latestTime":"11-07 16:00:00 EST","open":19,"high":19,"low":19,"amount":75309517.295535,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.479806,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1349928000000,"exchange":"NASDAQ","adjPreClose":19,"volumeRatio":0},"requestUrl":"/m/hq/s/ICPT","defaultTab":"news","newsList":[{"id":"2476121426","title":"BRIEF-Intercept Pharmaceuticals FDA Informed It Is Continuing Its Review Of SNDA For Full Approval Of Ocaliva","url":"https://stock-news.laohu8.com/highlight/detail?id=2476121426","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476121426?lang=en_us&edition=fundamental","pubTime":"2024-10-17 21:05","pubTimestamp":1729170332,"startTime":"0","endTime":"0","summary":"Oct 17  -    * INTERCEPT PHARMACEUTICALS: FDA INFORMED IT IS CONTINUING ITS REVIEW OF SNDA FOR FULL APPROVAL OF OCALIVA   * INTERCEPT PHARMACEUTICALS:  FDA INFORMED ITS ACTION UNDER PDUFA FOR OCALIVA EXPECTED ON OCTOBER 15 HAS BEEN DELAYEDSource text for Eikon:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICPT","SNDA","BK4185","BK4139"],"gpt_icon":0},{"id":"2471380651","title":"Adeia to Present at Upcoming Conferences on Hybrid Bonding Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2471380651","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471380651?lang=en_us&edition=fundamental","pubTime":"2024-09-30 19:27","pubTimestamp":1727695620,"startTime":"0","endTime":"0","summary":"SAN JOSE, Calif., Sept.  30, 2024  (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), a leader in invention of semiconductor technology, announced that several of its semiconductor technologists will pres","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/09/30/2955085/0/en/Adeia-to-Present-at-Upcoming-Conferences-on-Hybrid-Bonding-Technology.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADEA","BK4139","ICPT","BK4097"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.interceptpharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis and NASH; and other product candidates in various stages of clinical and preclinical development. The company has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. It markets its products through an internal commercial organization and third-party distributors. The company was incorporated in 2002 and is headquartered in Morristown, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":0.818182,"avgChangeRate":0.410118},{"month":2,"riseRate":0.454545,"avgChangeRate":0.001426},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.019635},{"month":4,"riseRate":0.363636,"avgChangeRate":0.005796},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.059597},{"month":6,"riseRate":0.545455,"avgChangeRate":0.014781},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.009691},{"month":8,"riseRate":0.545455,"avgChangeRate":0.03306},{"month":9,"riseRate":0.454545,"avgChangeRate":0.028553},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.062148},{"month":11,"riseRate":0.666667,"avgChangeRate":0.064475},{"month":12,"riseRate":0.454545,"avgChangeRate":0.022746}],"exchange":"NASDAQ","name":"Intercept Pharmaceuticals","nameEN":"Intercept Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Intercept Pharmaceuticals(ICPT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Intercept Pharmaceuticals(ICPT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Intercept Pharmaceuticals,ICPT,Intercept Pharmaceuticals股票,Intercept Pharmaceuticals股票老虎,Intercept Pharmaceuticals股票老虎国际,Intercept Pharmaceuticals行情,Intercept Pharmaceuticals股票行情,Intercept Pharmaceuticals股价,Intercept Pharmaceuticals股市,Intercept Pharmaceuticals股票价格,Intercept Pharmaceuticals股票交易,Intercept Pharmaceuticals股票购买,Intercept Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Intercept Pharmaceuticals(ICPT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Intercept Pharmaceuticals(ICPT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction